Ever found yourself in severe pain from a cut wound or minor injury yet still required to wait in line at the hospital for medical attention because it's not considered serious enough to be treated in the emergency room? Well, you need not fret no more the next time you require treatment! A local in...

Obesity has become a growing epidemic moving at a staggering rate as more than one million Western Australians are reported to be overweight, according to a new research commissioned by HBF, a local provider of health insurance.

Gaming consoles have long replaced television and social interaction for kids, where they feel more at home with the make-believe world of a video game than with others their own age. Though shooting down bad guys, slaying dragons and rescuing damsels in distress may seem for some, like a harmless p...

Still no definite news about what's going on at Sigma Pharmaceuticals.

Local health authorities have earned the confidence of Australians by being prepared and equipped in handling the swine flu outbreak by ensuring the public were kept well informed during the pandemic.

After a solid result for the December 31 half year, the company said yesterday that it was on track to meet full year guidance after a strong half year.

Neil Ian Leggett, the former managing director of biotechnology group Aginex, was yesterday sentenced for nine years in jail after being found guilty of stealing $5.5 million from the company between 2006 and 2008.

Shares in CSL Ltd, the country's major pharmaceutical group, rose strong yesterday after a bullish outlook from the company and CEO Brian McNamee.

Private healthcare group Healthscope yesterday recorded a 17 per cent increase in their interim profit, but still failed to meet market expectations mainly due to a collapsed takeover of an aged-care centre last week.

Hospital group Healthscope's proposed takeover of aged-care center Arcare has been called off, the group's chief executive Bruce Dixon announced last night.

CSL Biotherapies, a subsidiary of CSL - Australia's leading biopharmaceutical company, can today confirm that 100% of deliveries of its H1N1 influenza vaccine are being completed on time in all States.

Japan's Taisho Pharmaceutical Co. Ltd. said Wednesday it will buy Bristol-Myers Squibb Co.'s over-the-counter drug assets worth US$310 million in Asia Pacific (excluding China and Japan).

Shares in Australian biotherapies group CSL Ltd rose 3 percent after it beat market expectations with a 63 percent rise in full year profit and gave an upbeat forecast.

Cochlear Ltd, the world's top maker of hearing implants, expects growth this year to be weighted to the second half as it awaits approvals for new products, the company said on Tuesday.

Hearing implant maker Cochlear has had its earnings undercut by the rising Australian dollar.

The World Health Organization is calling on drug-makers to manufacture a vaccine against the new H1N1 virus, commonly known as the "swine flu."

An increase in the cigarette tax could see tobacco smuggling flourish according to customs officials.

British drugmaker GlaxoSmithKline said its Asia-Pacific sales could double in five years as growing prosperity boosts demand for better healthcare and as it cuts prices in some Asian countries.

Australia best prepared to deal with swine flu, according to the PM.